Company intelligence / Profile preview

Green Paw

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Green Paw is a pet wellness company that specializes in the development and commercialization of hemp-derived CBD products specifically formulated for companion animals. The company focuses on addressing common veterinary concerns such as anxiety, joint pain, and inflammation through high-quality, lab-tested supplements. Their product line includes oils, treats, and topical applications designed to improve the overall quality of life for dogs and cats. By leveraging natural therapeutic compounds, Green Paw aims to provide safe and effective alternatives to traditional pharmacological interventions in the pet health market.

Therapeutic areas: RheumatologyPsychiatryNeurologyImmunology
Modalities: Small moleculeNatural products
Industry: Veterinary

Beyond the preview

Go deeper on Green Paw.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Green Paw.

Explore the full profile